Related Experiment Video
Updated: Jan 19, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Epicutaneous sensitization to food allergens in atopic dermatitis: What do we know?
Elizabeth Huiwen Tham1,2, Mohana Rajakulendran2, Bee Wah Lee1
1Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Insights
Atopic dermatitis (AD) in children often persists and can lead to food allergies. Early interventions and biomarkers are crucial to prevent the progression of allergic diseases.
Area of Science:
- Immunology
- Dermatology
- Allergology
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin condition affecting many children, with limited curative options.
- Epithelial barrier dysfunction in AD is linked to developing food allergies and other allergic conditions.
- The 'atopic march' describes the progression from AD to other allergic diseases like asthma and allergic rhinitis.
Purpose of the Study:
- To explore mechanisms of epicutaneous sensitization to food allergens in AD.
- To review interventions for preventing AD progression to food allergy.
- To identify research gaps and future directions in AD management.
Main Methods:
- Literature review of studies on atopic dermatitis and food sensitization.
- Analysis of evidence for prophylactic and secondary preventive strategies.
- Examination of biomarkers for targeted AD therapy.
Main Results:
- Prophylactic emollient use may prevent AD, but biomarkers are needed for targeted prevention.
- Secondary prevention strategies are essential to curb the progression to food allergy, asthma, and rhinitis.
- Understanding sensitization mechanisms is key to developing effective interventions.
Conclusions:
- Effective biomarkers and targeted therapies are needed for primary AD prevention.
- Secondary prevention strategies are critical to manage the atopic march.
- Further research is required to address unmet needs in AD and food allergy prevention.
Abstract:
Atopic dermatitis (AD) is a chronic inflammatory skin disease mainly affecting children, which has no definitive curative therapy apart from natural outgrowing. AD is persistent in 30%-40% of children. Epithelial barrier dysfunction in AD is a significant risk factor for the development of epicutaneous food sensitization, food allergy, and other allergic disorders. There is evidence that prophylactic emollient applications from birth may be useful for primary prevention of AD, but biomarkers are needed to guide cost-effective targeted therapy for high-risk individuals. In established early-onset AD, secondary preventive strategies are needed to attenuate progression to other allergic disorders such as food allergy, asthma, and allergic rhinitis (the atopic march). This review aims to describe the mechanisms underpinning the development of epicutaneous sensitization to food allergens and progression to clinical food allergy; summarize current evidence for interventions to halt the progression from AD to food sensitization and clinical food allergy; and highlight unmet needs and directions for future research.
Related Concept Videos
Allergic Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Clinical Applications of Epidermal Stem Cells
Cross-reactivity
Sensory Functions of the Skin
There are two main categories of receptors on the skin: capsulated and non-capsulated. The non-capsulated ones are mainly the pain receptors. The capsulated ones can be further categorized based on the...
Allergic Drug Reactions

